CoVet
PrivateLast Round
Grant
Jan 8, 2026
Total Funding Raised
$25,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CoVet operates in Healthcare & Life Sciences and is based in Burlington. Its latest recorded funding round was a Grant round in January 2026.
CoVet is a business/productivity software company that provides an AI-powered veterinary copilot to generate medical records and automate administrative work for veterinary professionals.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Medical AI, NLP & Conversational AI, Document Management
Business Model
B2B
Customer Profile
Subscription SaaS, Freemium, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CoVet Comparables
Compare CoVet with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HappyDoc | 92% | |
| VetRec | 92% | |
| Scribenote | 91% |
For institutional investors. Book with your work email.
CoVet Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 8, 2026 | ||||
| Growth Equity | Sep 2, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 23, 2026
Grew 28% QoQ, from 103 to 132 employees.
- May 25, 2026
Grew 30% QoQ, from 92 to 120 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- signs_new_clientSep 29, 2026
Tierarzt Plus Partner selected CoVet, Inc. as its exclusive AI-powered clinical documentation solution across its German veterinary-practice network, beginning with more than 30 practices and expanding more broadly.
- integrates_withSep 22, 2026
CoVet, Inc. is set to integrate into the IDEXX Laboratories, Inc. software ecosystem in Sep '26 while continuing to support non-IDEXX Laboratories, Inc. practice management systems.
- partners_withSep 14, 2026
On Sep 14th '26, CoVet, Inc. and Vet form a strategic partnership to bring smarter technology to veterinary practices and create more practice efficiencies.
For institutional investors. Book with your work email.
CoVet Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CoVet's valuation, stock price, and market status.
Is CoVet a public or private company?
CoVet is a private company.
What is the current stock price of CoVet?
CoVet is a private company, so its shares have no public market price. Caplight tracks CoVet's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CoVet worth (valuation)?
Valuation information for CoVet is not publicly available.
Can I buy CoVet stock?
CoVet shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CoVet's last funding round?
CoVet's most recent funding round was Grant on January 8, 2026.
Who are the main investors in CoVet?
Investor information for CoVet is not publicly disclosed.
Will CoVet IPO soon?
No public IPO plans have been announced for CoVet.
How can I track CoVet secondary market activity?
Caplight tracks bids, offers, and trades in CoVet's shares on secondary markets.